Paraquat and Parkinson's disease

Warner TT, Schapira AH . Genetic and environmental factors in the cause of Parkinson's disease. Ann Neurol 2003; 53 (Suppl 3): S16–S23; discussion S23-25.

Schapira AH . Neurobiology and treatment of Parkinson's disease. Trends Pharmacol Sci 2009; 30: 41–47.

Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003; 18: 467–486.

Barbeau A . Manganese and extrapypamidal disorders (a critical review and tribute to Dr. Georg C. Cotzias). Neurotoxicology 1984; 5: 13–35.

Li AA, Mink PJ, McIntosh LJ, Teta MJ, Finley B . Evaluation of epidemiologic and animal data associating pesticides with Parkinson's disease. J Occup Environ Med 2005; 47: 1059–1087.

Brown TP, Rumsby PC, Capleton AC, Rushton L, Levy LS . Pesticides and Parkinson's disease--is there a link? Environ Health Perspect 2006; 114: 156–164.

Engel LS, Checkoway H, Keifer MC, Seixas NS, Longstreth Jr WT, Scott KC et al. Parkinsonism and occupational exposure to pesticides. Occup Environ Med 2001; 58: 582–589.

Baldi I, Lebailly P, Mohammed-Brahim B, Letenneur L, Dartigues JF, Brochard P . Neurodegenerative diseases and exposure to pesticides in the elderly. Am J Epidemiol 2003; 157: 409–414.

Frigerio R, Sanft KR, Grossardt BR, Peterson BJ, Elbaz A, Bower JH et al. Chemical exposures and Parkinson's disease: a population-based case-control study. Mov Disord 2006; 21: 1688–1692.

Ascherio A, Chen H, Weisskopf MG, O’Reilly E, McCullough ML, Calle EE et al. Pesticide exposure and risk for Parkinson's disease. Ann Neurol 2006; 60: 197–203.

Dick FD, De Palma G, Ahmadi A, Scott NW, Prescott GJ, Bennett J et al. Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study. Occup Environ Med 2007; 64: 666–672.

Seidler A, Hellenbrand W, Robra BP, Vieregge P, Nischan P, Joerg J et al. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology 1996; 46: 1275–1284.

Liou HH, Tsai MC, Chen CJ, Jeng JS, Chang YC, Chen SY et al. Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 1997; 48: 1583–1588.

Kuopio AM, Marttila RJ, Helenius H, Rinne UK . Environmental risk factors in Parkinson's disease. Mov Disord 1999; 14: 928–939.

Firestone JA, Smith-Weller T, Franklin G, Swanson P, Longstreth Jr WT, Checkoway H . Pesticides and risk of Parkinson disease: a population-based case-control study. Arch Neurol 2005; 62: 91–95.

Kamel F, Tanner C, Umbach D, Hoppin J, Alavanja M, Blair A et al. Pesticide exposure and self-reported Parkinson's disease in the agricultural health study. Am J Epidemiol 2007; 165: 364–374.

Hertzman C, Wiens M, Bowering D, Snow B, Calne D . Parkinson's disease: a case-control study of occupational and environmental risk factors. Am J Ind Med 1990; 17: 349–355.

Hertzman C, Wiens M, Snow B, Kelly S, Calne D . A case-control study of Parkinson's disease in a horticultural region of British Columbia. Mov Disord 1994; 9: 69–75.

Liou HH, Chen RC, Chen THH, Tsai YF, Tsai MC . Attenuation of paraquat-induced dopaminergic toxicity on the substantia nigra by (-)-deprenyl in vivo. Toxicol Appl Pharmacol 2001; 172: 37–43.

Tanner CM, Ross GW, Jewell SA, Hauser RA, Jankovic J, Factor SA et al. Occupation and risk of parkinsonism: a multicenter case-control study. Arch Neurol 2009; 66: 1106–1113.

Costello S, Cockburn M, Bronstein J, Zhang X, Ritz B . Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. Am J Epidemiol 2009; 169: 919–926.

Ritz BR, Manthripragada AD, Costello S, Lincoln SJ, Farrer MJ, Cockburn M et al. Dopamine transporter genetic variants and pesticides in Parkinson's disease. Environ Health Perspect 2009; 117: 964–969.

Ioannidis JP, Trikalinos TA, Khoury MJ . Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. Am J Epidemiol 2006; 164: 609–614.

Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer 1976; 34: 585–612.

Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1–39.

McCarthy S, Somayajulu M, Sikorska M, Borowy-Borowski H, Pandey S . Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble coenzyme Q(10). Toxicol Appl Pharmacol 2004; 201: 21–31.

McCormack AL, Atienza JG, Johnston LC, Andersen JK, Vu S, Di Monte DA . Role of oxidative stress in paraquat-induced dopaminergic cell degeneration. J Neurochem 2005; 93: 1030–1037.

Bonneh-Barkay D, Langston WJ, Di Monte DA . Toxicity of redox cycling pesticides in primary mesencephalic cultures. Antioxid Redox Signal 2005; 7: 649–653.

Bonneh-Barkay D, Reaney SH, Langston WJ, Di Monte DA . Redox cycling of the herbicide paraquat in microglial cultures. Mol Brain Res 2005; 134: 52–56.

Murray RE, Gibson JE . Paraquat disposition in rats, guinea pigs and monkeys. Toxicol Appl Pharmacol 1974; 27: 283–291.

Widdowson PS, Farnworth MJ, Upton R, Simpson MG . No changes in behaviour, nigro-striatal system neurochemistry or neuronal cell death following toxic multiple oral paraquat administration to rats. Hum Exp Toxicol 1996; 15: 583–591.

Naylor JL, Widdowson PS, Simpson MG, Farnworth M, Ellis MK, Lock EA . Further evidence that the blood-brain-barrier impedes paraquat entry into the brain. Hum Exp Toxicol 1995; 14: 587–594.

Shimizu K, Ohtaki K, Matsubara K, Aoyama K, Uezono T, Saito O et al. Carrier-mediated processes in blood-brain barrier penetration and neural uptake of paraquat. Brain Res 2001; 906: 135–142.

Corasaniti MT, Strongoli MC, Pisanelli A, Bruno P, Rotiroti D, Nappi G et al. Distribution of paraquat into the brain after its systemic injection in rats. Funct Neurol 1992; 7: 51–56.

Corasaniti MT, Defilippo R, Rodino P, Nappi G, Nistico G . Evidence that paraquat is able to cross the blood-brain barrier to a different extent in rats of various age. Funct Neurol 1991; 6: 385–391.

Langston JW, Ballard P, Tetrud JW, Irwin I . Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science (New York, NY) 1983; 219: 979–980.

Ossowska K, Smialowska M, Kuter K, Wieronska J, Zieba B, Wardas J et al. Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: Implications for Parkinson's disease. Neuroscience 2006; 141: 2155–2165.

Ramachandiran S, Hansen JM, Jones DP, Richardson JR, Miller GW . Divergent mechanisms of paraquat, MPP+, and rotenone toxicity: oxidation of thioredoxin and caspase-3 activation. Toxicol Sci 2007; 95: 163–171.

Richardson JR, Quan Y, Sherer TB, Greenamyre JT, Miller GW . Paraquat neurotoxicity is distinct from that of MPTP and rotenone. Toxicol Sci 2005; 88: 193–201.

McCormack AL, Atienza JG, Langston JW, Di Monte DA . Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to paraquat-induced degeneration. Neuroscience 2006; 141: 929–937.

Cocheme HM, Murphy MP . Complex I is the major site of mitochondrial superoxide production by paraquat. J Biol Chem 2008; 283: 1786–1798.

Choi WS, Kruse SE, Palmiter RD, Xia Z . Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat. Proc Natl Acad Sci USA 2008; 105: 15136–15141.

Doostzadeh J, Davis RW, Giaever GN, Nislow C, Langston JW . Chemical genomic profiling for identifying intracellular targets of toxicants producing Parkinson's disease. Toxicol Sci 2007; 95: 182–187.

Ved R, Saha S, Westlund B, Perier C, Burnam L, Sluder A et al. Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans. J Biol Chem 2005; 280: 42655–42668.

Schapira AH . Neuroprotection and dopamine agonists. Neurology 2002; 58 (4 Suppl 1): S9–18.

Liu B . Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease. AAPS J 2006; 8: E606–E621.

Wu XF, Block ML, Zhang W, Qin L, Wilson B, Zhang WQ et al. The role of microglia in paraquat-induced dopaminergic neurotoxicity. Antioxid Redox Signal 2005; 7: 654–661.

Strauss KM, Martins LM, Plun-Favreau H, Marx FP, Kautzmann S, Berg D et al. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum Mol Genet 2005; 14: 2099–2111.

Plun-Favreau H, Klupsch K, Moisoi N, Gandhi S, Kjaer S, Frith D et al. The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat Cell Biol 2007: 1243–1252.

Thomas B, Beal MF . Parkinson's disease. Human Mol Genet 2007; 16 (Spec No 2): R183–R194.

Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA . The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice - Paraquat and alpha-synuclein. J Biol Chem 2002; 277: 1641–1644.

Manning-Bog AB, McCormack AL, Purisai MG, Bolin LM, Di Monte DA . alpha-synuclein overexpression protects against paraquat-induced neurodegeneration. J Neurosci 2003; 23: 3095–3099.

Wang C, Ko HS, Thomas B, Tsang F, Chew KC, Tay SP et al. Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function. Human Mol Genet 2005; 14: 3885–3897.

Uversky VN, Li J, Fink AL . Pesticides directly accelerate the rate of alpha-synuclein fibril formation: a possible factor in Parkinson's disease. FEBS Lett 2001; 500: 105–108.

Cory-Slechta DA, Thiruchelvam M, Barlow BK, Richfield EK . Developmental pesticide models of the Parkinson disease phenotype. Environ Health Perspect 2005; 113: 1263–1270.

Barlow BK, Richfield EK, Cory-Slechta DA, Thiruchelvam M . A fetal risk factor for Parkinson's disease. Dev Neurosci 2004; 26: 11–23.

Thiruchelvam M, Richfield EK, Goodman BM, Baggs RB, Cory-Slechta DA . Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype. Neurotoxicology 2002; 23: 621–633.

Ling Z, Gayle DA, Ma SY, Lipton JW, Tong CW, Hong JS et al. In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Mov Disord 2002; 17: 116–124.

Purisai MG, McCormack AL, Cumine S, Li J, Isla MZ, Di Monte DA . Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration. Neurobiol Dis 2007; 25: 392–400.

Kitazawa M, Oddo S, Yamasaki TR, Green KN, LaFerla FM . Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J Neurosci 2005; 25: 8843–8853.